Innovent Biologics (suzhou) Co. Ltd.

This study tests an experimental drug, IBI356, in 403 adults with moderate to severe atopic dermatitis (eczema). Participants receive either the drug or a placebo to see if it reduces skin redness, itching, and rash. The goal is to control the disease, not cure it, and results wi…

This study tests a new medicine called IBI311 for people with inactive thyroid eye disease, a condition that causes the eyes to bulge. The goal is to see if the drug can reduce eye bulging by at least 2 millimeters. About 111 adults will take part, and the study lasts up to 64 we…